Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Consequently, Pharma companies are increasingly including real-world studies in their evidence to:
• Understand the opportunities and best practices for involving patient partners in the generation of real-world evidence
• Explore, using case studies, the value of patient engagement in the design, delivery, analysis and communication of real-world studies
• Highlight the importance of Medical Affairs and Health Economics and Outcomes Research (HEOR) professionals in partnering with colleagues from different functions in Pharma to ensure patients are effectively engaged throughout the product lifecycle
• Discuss barriers and propose solutions to optimal patient engagement in real-world studies
This webinar, hosted by the MAPS APAC Chapter, aims to provide a comprehensive and practical overview of how Artificial Intelligence (AI) can be integrated into various functions of Medical Affairs. Attendees will gain insights into the application of AI in medical strategy, note-taking during advisory boards, setting agendas, and enhancing scientific communication. By the end of the session, participants will have a clear understanding of the tools and techniques available, and how to implement them effectively to improve efficiency and outcomes in their roles.
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.
In this discussion, you’ll learn:
The objective is to illustrate how the strategic incorporation of interactive tools, visualization, and personalization of content can elevate the communication of medical and scientific information making it more accessible, engaging, and meaningful for diverse audiences. By embracing the innovative techniques from journalism, Medical Affairs professionals can build stronger communications with their audience, allowing for audiences to determine what they choose to view, in what order, and to the level of complexity they prefer. The presentation aims to be a facilitator for innovation, inspiring Medical Affairs professionals to adopt and adapt journalistic interactivity and visualization to their communication strategies.
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches. Learn from industry experts about the strategic goals of Medical Affairs and its unique impact generation in a cross-functional environment. Discover essential metrics for assessing performance and best practices for implementation. Explore cutting-edge data generation methods and technological advancements to enhance data quality and impact measurement.
Key topics to be addressed include:
What is the strategic goal of Medical Affairs and how does it generate impact?
What are the key metrics to measure Medical Affairs’ performance and impact?
How can innovative data approaches enhance measuring Medical Affairs’ impact?
By the end of this webinar, attendees should...
1. Be able to articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
2. Be confident to follow clear methodologies to incorporate the patient voice within publications and the role of Medical Affairs in disease awareness campaigns.
3. Be able to implement best practice approaches including novel ways to disseminate information.
Omnichannel communication holds the promise of reshaping interactions between the pharmaceutical industry and healthcare professionals (HCPs), revolutionizing engagement through personalized and seamless connections. Medical Affairs teams are in a unique position to engage with and provide HCPs with the information and education they seek, including in-depth clinical data, additional analyses and treatment updates. While Medical Affairs teams have the capacity to harness this transformative power, the pharmaceutical industry has been slow to fully embrace this revolution. Crafting effective omnichannel strategies remains a formidable challenge, laden with barriers.
Our webinar offers a platform for attendees to engage with a diverse group of Medical Affairs omnichannel experts, discover their distinctive perspectives, navigate common obstacles, and gain firsthand insights into pragmatic omnichannel integration solutions.
Key areas of focus will include:
·     Unpacking Omnichannel Strategies: Understanding the added value for customers and organizations, and the need to diverge from conventional single or multichannel approaches
·     Overcoming Barriers: Identifying and surmounting the obstacles hindering Medical Affairs teams' success with omnichannel, and exploring actionable solutions
·     Forging the Path to Omnichannel Success: Strategic drivers and actions, and how to institute them effectively across organizational landscapes.
The Medical Affairs landscape is rapidly evolving, demanding field medical teams to engage with a wide range of stakeholders. MSLs are expected to handle over 350 interactions annually and manage numerous stakeholders, a number which continues to rise. However, simply increasing interaction numbers without addressing associated challenges like reaching out to the right stakeholders or gaining access to them is ineffective. It's crucial for organizations to acknowledge and tackle these obstacles effectively. By doing so, they can redefine engagement strategies, ensuring meaningful interactions tailored to stakeholders' needs. This approach will allow organizations to move beyond mere volume-based metrics, focusing instead on the genuine productivity and impact of their field medical teams. Over the course of time, this will also lead to better relationships being developed with key scientific stakeholders.
This webinar discusses the current focus on volume-based metrics as a measure and will also help the participants understand some key considerations around volume-based metrics while redefining the industry thinking on this important topic.
Join us for an exciting webinar, co-organized by KSPM and MAPS, that will highlight the critical role of Medical Affairs in the healthcare industry. Industry experts from Korea and global will discuss the strategic value and tangible impact Medical Affairs professionals make in advancing patient care and driving pharmaceutical innovation.
Don’t miss this opportunity to gain insights and join the conversation on the evolving landscape of Medical Affairs!
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.